EYE Think is where Ora explores the ideas, challenges, and opportunities shaping the future of ophthalmology research. These articles offer Ora’s take on a changing industry, from clinical trial complexity and patient selection to innovation, endpoints, and the decisions that help move research forward.
The trouble with trials for the front of the eye
Anterior segment trials may start at the surface, but the work quickly gets more complicated: finding the right patients, choosing the right endpoints, and proving what truly works.
A.I. might be the best study coordinator you’ve never met
A look at how AI may help teams identify the right patients, streamline study planning, and see trial complexity more clearly.
It’s time to turn down the noise in dry eye trials
Dry eye trials can be full of variability. This piece looks at how sharper endpoints, controlled environments, and smarter study design can help reveal what really matters.
We need a new lens on clinical trials
A look at why ophthalmology trials demand more than execution alone, from thoughtful study design to the collaboration needed to move research forward.
